<DOC>
	<DOCNO>NCT01621308</DOCNO>
	<brief_summary>Almost patient type 1 diabetes mellitus ( T1DM ) need insulin treatment permanently . For selected patient unable achieve glycaemic target subcutaneous ( SC ) insulin treatment , continuous intraperitoneal ( IP ) insulin infusion third-line alternative . Previous study demonstrate continuous intraperitoneal insulin infusion ( CIPII ) use implantable pump device improve glycaemic control quality life patient 'brittle ' T1DM . Nevertheless , literature compare IP SC insulin treatment scarce . The primary objective study compare effect IP insulin delivery SC insulin delivery.The null hypothesis ( H0 ) current study hold inferiority CIPII compare SC insulin regard long-term glycaemic control . The alternative hypothesis ( H1 ) inverse : CIPII non-inferior SC insulin . In summary , H0 : CIPII inferior SC insulin treatment H1 : CIPII inferior SC insulin treatment This investigator initiate , open label prospective matched-control study non-inferiority design . The trial duration 36 week conduct single-centre ( Isala Clinics , Zwolle ) . If non-inferiority establish superiority analysis perform .</brief_summary>
	<brief_title>Intraperitoneal vs Subcutaneous Insulin Administration Type 1 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Case inclusion criterion T1DM If subject CIPII , must include ( 8 ) If subject CIPII , n't participate ( 8 ) , must CIPII start previous study ( 8 ) If subject CIPII , must CIPII past 4 year without interruption ( &gt; 30 day ) Proper knowledge Dutch language . Case exclusion criterion Impaired renal function ( plasma creatinine ≥150 µmol/L glomerular filtration rate estimate CockcroftGault formula ≤50ml/min ) Cardiac problem ( unstable angina myocardial infarction within previous 12 month New York Heart Association class III IV congestive heart failure Mentally handicap Current past psychiatric treatment schizophrenia Cognitive bipolar disorder Current use oral corticosteroid suffer condition necessitate oral systemic corticosteroid use previous 12 month Substance abuse , nicotine Current gravidity plan become pregnant trial Plans engage activity require go &gt; 25 foot sea level Any condition investigator and/or coordinate investigator feel would interfere trial participation evaluation result . 4.4 Control inclusion criterion T1DM SC insulin mode insulin administration If subject SC insulin , must SC insulin past 4 year without interruption ( &gt; 30 day ) HbA1c time matching must ≥7.0 % ( 53mmol/mol ) Proper knowledge Dutch language . Control exclusion criterion Impaired renal function ( plasma creatinine ≥150 µmol/L glomerular filtration rate estimate CockcroftGault formula ≤50ml/min ) Cardiac problem ( unstable angina myocardial infarction within previous 12 month New York Heart Association class III IV congestive heart failure Mentally handicap Current past psychiatric treatment schizophrenia Cognitive bipolar disorder Current use oral corticosteroid suffer condition necessitate oral systemic corticosteroid use previous 12 month Substance abuse , nicotine Current gravidity plan become pregnant trial Plans engage activity require go &gt; 25 foot sea level Any condition investigator and/or coordinate investigator feel would interfere trial participation evaluation result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Diabetes Mellitus type 1</keyword>
	<keyword>Intraperitoneal insulin administration</keyword>
	<keyword>Subcutaneous insulin administration</keyword>
	<keyword>Continuous intraperitoneal insulin infusion</keyword>
</DOC>